Clinical Trials in Hengshui, China
1 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 2
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Acute Ischemic Stroke
Shanghai Pharmaceuticals Holding Co., Ltd300 enrolled28 locationsNCT05686642
Recruiting
Phase 3
A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
AIS
Biocells (Beijing) Biotech Co.,Ltd1,112 enrolled9 locationsNCT07520565
Recruiting
Phase 2
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Acute Ischemic Stroke
Kunming Pharmaceuticals, Inc.300 enrolled23 locationsNCT07279493
Recruiting
Phase 2
A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.
Biliary Tract or Colorectal Cancer With Her2-positive/Mutated
Shanghai Pharmaceuticals Holding Co., Ltd60 enrolled30 locationsNCT06434597